Astrazeneca Plc (AZN)
$55.30 1.15 (2.04%)
6:58 EDT AZN Stock Quote Delayed 30 Minutes
Previous Close $56.45
Market Cap 140.09B
PE Ratio 49.92
Volume (Avg. Vol.) 30,321
Day's Range 56.45 - 56.45
52-Week Range 36.15 - 64.94
Dividend & Yield 1.37 (2.48%)
AZN Stock Predictions, Articles, and Astrazeneca Plc News
- From InvestorPlace
- From the Web
By Thomas Niel
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)
The pandemic isn't the only reason you should be looking a pharmaceutical stocks. Here are six pharma companies that stand out with or without Covid-19.
Stocks to buy for beginners for different sectors. Focus on defensive stocks with low beta and robust cash flows.
Biotech stocks are on fire at the moment. That said, here are five names from the sector that offer long-term value and strong fundamentals.
By Ian Cooper
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
Moderna, UnitedHeath, Beyond Meat, American Airlines and AstraZeneca were our top stock trades from Wednesday -- and here's why.
These international stocks offer investors geographically diversified exposure and get a bigger bump as countries open up for business.
Lululemon Athletica, Nvidia, TJX Companies and AstraZeneca were our top stock trades for Friday. That said, let's look at the charts.
By Ian Cooper
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.
There's a new Sanofi CEO preparing to join the company with current CEO Olivier Brandicourt retiring at the end of August.
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
The stock charts of PGR, LB and PKG are going to start the new trading week on the cusp of major moves that have been forming for weeks.
AstraZeneca announced that it has inked a deal with Daiichi Sankyo to improve its oncology branch. AZN stock is down more than 5% on Friday.
An AstraZeneca earnings beat for the pharmaceutical company's fourth quarter of 2018 has AZN stock heading higher on Thursday.
Don't ignore Dow Jones stocks. They can still power your portfolio. Here are 5 of the best to own in 2019 and beyond!
AstraZeneca's profits are poised to accelerate, but investors should wait for AZN stock to break out of its range before buying the shares.
BIIB stock jumped on Friday, and for good reason. It's not a buy at these lofty levels, but Biogen has at least earned a spot on your watchlist.
Navellier RatingsPowered by Portfolio Grader